Implementing DPYD testing to guide fluoropyrimidine dosing in cancer care: The time is now!
Description:
Dr. Tuteja is the Director of Pharmacogenomics in the Penn Medicine Center for Genomic Medicine at the University of Pennsylvania and Assistant Professor in the Department of Medicine, Division of Translational Medicine and Human Genetics. She is a clinical pharmacist and translational researcher with expertise in genomic, translational, and implementation research. Her work focuses on 1) the implementation of pharmacogenomics into clinical care to improve medication safety and 2) the discovery of novel pharmacogenomic markers of drug response using electronic health record data (EHR) coupled with large DNA repositories. Dr. Tuteja received her Doctor of Pharmacy degree from the University of Michigan and her Masters in Translational Research from the University of Iowa. She also completed a post-doctoral fellowship in pharmacogenomics at the University of Pennsylvania.
Speaker:
Sony Tuteja, PharmD, MS, MCPS, FAHA, FCCP
Perelman School of Medicine, University of PennsylvaniaModerator:
Federico A. Monzon, MD
Delphi Diagnostics Inc.
Duration: 1 hour
Level of Instruction: Basic
Date Recorded: July 31, 2025
Continuing Education credit (CME, CMLE) is NOT available for this activity.
This
webinar was hosted by AMP’s International Affairs Committee.
Established in 2010, the committee endeavors to advance molecular pathology
around the globe through educational and professional activities. Committee
members and international affiliates work in more than 50 countries.
Note: Join the AMP Family for discounted access to the most current educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation.